Alpha-Synuclein NEALS Presentation

On Wednesday, November 2th, Dr. Smith's abstract regarding alpha-synuclein seed-amplification was presented at the NEALS convention in Clearwater, Florida.

The presentation was given by one of the authors, Dr. Robert Bowser and the poster that was presented is below.

Screen Shot 2022-12-01 at 12.53.11 PM.png

June 5, 2012 – At the invitation of ALS Association and NEALS, Dr. Smith discussed the scientific basis for an upcoming ALS clinical trial in a webinar entitled: "Determining the Effect of Nuedexta on Speech and Swallowing in ALS: A Multicenter Trial"

February 17, 2012 – Dr. Smith spoke at Cedar-Sinai in Los Angeles.

March 8, 2012 – Dr. Smith spoke at the Packard Conference in John Hopkins.

FDA approves Nuedexta which was discovered at CNS and developed by Avanir pharmaceutical corporation.

November 5, 2011 – Dr. Smith spoke at Neurology grand rounds at Stanford.

June 27-28, 2011 – At the California ALS Summit, held in San Francisco, Dr. Smith gave a talk entitled "The ALS phenotype: lost in translation" and chaired a session dealing with molecular therapy for ALS.

October 1, 2011 – This presentation, titled "Developing therapeutics for amyotrophic lateral sclerosis," to ALS patients/families, sponsored by the ALS association, was made by Dr. Smith in connection with the 2011 California ALS summit.